Should we withhold angiotensin converting enzyme inhibitors before anaesthesia? An updated debate on the pros and cons

J Clin Anesth. 2017 Nov:42:51-52. doi: 10.1016/j.jclinane.2017.07.008. Epub 2017 Aug 15.

Authors

Michele Claudio Vassallo¹, Fabiana Tartamella², Filippo Testa³

Affiliations

¹ Department of Cardiac Anaesthesia and Intensive Care, Luigi Sacco University Hospital, Via GB Grassi 74, 20157 Milan, Italy. Electronic address: [email protected].
² Department of Cardiac Anaesthesia and Intensive Care, Luigi Sacco University Hospital, Via GB Grassi 74, 20157 Milan, Italy.
³ Department of Cardiac Anaesthesia, Cattinara University Hospital, Strada di Fiume 447, 34149 Trieste, Italy.

PMID: 28821004
DOI: 10.1016/j.jclinane.2017.07.008

No abstract available

Keywords: Anaesthesia; Angiotensin converting enzyme inhibitors; Angiotensin receptor.

Publication types

Letter

MeSH terms

Acute Kidney Injury / epidemiology
Acute Kidney Injury / etiology
Anesthesia / adverse effects*
Anesthesia / methods
Angiotensin Receptor Antagonists / adverse effects*
Angiotensin Receptor Antagonists / standards
Angiotensin-Converting Enzyme Inhibitors / adverse effects*
Angiotensin-Converting Enzyme Inhibitors / standards
Clinical Decision-Making / methods
Humans
Hypertension / epidemiology
Hypertension / etiology
Hypotension / chemically induced*
Intraoperative Complications / epidemiology*
Intraoperative Complications / etiology
Postoperative Complications / epidemiology
Postoperative Complications / etiology
Practice Guidelines as Topic
Risk Assessment / methods
Risk Factors
Surgical Procedures, Operative / adverse effects*
Withholding Treatment / standards

Substances

Angiotensin Receptor Antagonists
Angiotensin-Converting Enzyme Inhibitors